BCM
PAHC icon

BlueCrest Capital Management’s Phibro Animal Health PAHC Stock Holding History

BlueCrest Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,984
Closed -$361K – 1029
2015
Q4 		$361K Buy
+11,984
New +$385K 0.02% 679

Other funds holding PAHC

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return

BlueCrest Capital Management's PAHC Position: Q1 2016 in Review

BlueCrest Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2016, closing a stake of 11,984 shares — an estimated $361K sold.

BlueCrest Capital Management first reported a position in PAHC in Q4 2015 and held it in 1 quarter. The position peaked at $361K in Q4 2015. 122 funds tracked by Wall St. Rank hold PAHC as of Q1 2016.

  • BlueCrest Capital Management reported no remaining Phibro Animal Health position as of Q1 2016 after selling out during the quarter.
  • BlueCrest Capital Management sold 11,984 Phibro Animal Health shares in Q1 2016, an estimated $361K.
  • BlueCrest Capital Management first reported a position in Phibro Animal Health in Q4 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's Phibro Animal Health position peaked at $361K in Q4 2015.
  • 122 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2016.

Based on BlueCrest Capital Management's 13F filing for Q1 2016, filed 3 May 2016.